Literature DB >> 19454698

The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.

Viviana P Ferreira1, Andrew P Herbert, Claudio Cortés, Kristi A McKee, Bärbel S Blaum, Stefan T Esswein, Dusan Uhrín, Paul N Barlow, Michael K Pangburn, David Kavanagh.   

Abstract

Factor H (fH) is essential for complement homeostasis in fluid-phase and on surfaces. Its two C-terminal domains (CCP 19-20) anchor fH to self-surfaces where it prevents C3b amplification in a process requiring its N-terminal four domains. In atypical hemolytic uremic syndrome (aHUS), mutations clustering toward the C terminus of fH may disrupt interactions with surface-associated C3b or polyanions and thereby diminish the ability of fH to regulate complement. To test this, we compared a recombinant protein encompassing CCP 19-20 with 16 mutants. The mutations had only very limited and localized effects on protein structure. Although we found four aHUS-linked fH mutations that decreased binding to C3b and/or to heparin (a model compound for cell surface polyanionic carbohydrates), we identified five aHUS-associated mutants with increased affinity for either or both ligands. Strikingly, these variable affinities for the individual ligands did not correlate with the extent to which all the aHUS-associated mutants were found to be impaired in a more physiological assay that measured their ability to inhibit cell surface complement functions of full-length fH. Taken together, our data suggest that disruption of a complex fH-self-surface recognition process, involving a balance of affinities for protein and physiological carbohydrate ligands, predisposes to aHUS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19454698      PMCID: PMC2696619          DOI: 10.4049/jimmunol.0804031

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Genetic studies into inherited and sporadic hemolytic uremic syndrome.

Authors:  P Warwicker; T H Goodship; R L Donne; Y Pirson; A Nicholls; R M Ward; P Turnpenny; J A Goodship
Journal:  Kidney Int       Date:  1998-04       Impact factor: 10.612

2.  The physiological breakdown of the third component of human complement.

Authors:  R A Harrison; P J Lachmann
Journal:  Mol Immunol       Date:  1980-01       Impact factor: 4.407

3.  The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts.

Authors:  V Fremeaux-Bacchi; E J Kemp; J A Goodship; M-A Dragon-Durey; L Strain; C Loirat; H-W Deng; T H J Goodship
Journal:  J Med Genet       Date:  2005-03-22       Impact factor: 6.318

4.  Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree.

Authors:  Jorge Esparza-Gordillo; Elena Goicoechea de Jorge; Cynthia Abarrategui Garrido; Luis Carreras; Margarita López-Trascasa; Pilar Sánchez-Corral; Santiago Rodríguez de Córdoba
Journal:  Mol Immunol       Date:  2006-01-18       Impact factor: 4.407

5.  Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis.

Authors:  A K Sharma; M K Pangburn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 6.  Complement regulatory genes and hemolytic uremic syndromes.

Authors:  David Kavanagh; Anna Richards; John Atkinson
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

7.  Implications of the progressive self-association of wild-type human factor H for complement regulation and disease.

Authors:  Ruodan Nan; Jayesh Gor; Stephen J Perkins
Journal:  J Mol Biol       Date:  2007-11-13       Impact factor: 5.469

8.  Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.

Authors:  M K Pangburn; R D Schreiber; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

9.  A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae.

Authors:  S Ram; A K Sharma; S D Simpson; S Gulati; D P McQuillen; M K Pangburn; P A Rice
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

10.  Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure.

Authors:  Andrew P Herbert; Dusan Uhrín; Malcolm Lyon; Michael K Pangburn; Paul N Barlow
Journal:  J Biol Chem       Date:  2006-03-13       Impact factor: 5.157

View more
  84 in total

Review 1.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

2.  Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement.

Authors:  Tommi Kajander; Markus J Lehtinen; Satu Hyvärinen; Arnab Bhattacharjee; Elisa Leung; David E Isenman; Seppo Meri; Adrian Goldman; T Sakari Jokiranta
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-01       Impact factor: 11.205

3.  Factor H-IgG Chimeric Proteins as a Therapeutic Approach against the Gram-Positive Bacterial Pathogen Streptococcus pyogenes.

Authors:  Anna M Blom; Michal Magda; Lisa Kohl; Jutamas Shaughnessy; John D Lambris; Sanjay Ram; David Ermert
Journal:  J Immunol       Date:  2017-10-30       Impact factor: 5.422

Review 4.  Review: Complement and its regulatory proteins in kidney diseases.

Authors:  Allison M Lesher; Wen-Chao Song
Journal:  Nephrology (Carlton)       Date:  2010-10       Impact factor: 2.506

5.  Structural basis for complement evasion by Lyme disease pathogen Borrelia burgdorferi.

Authors:  Arnab Bhattacharjee; Jesper S Oeemig; Robert Kolodziejczyk; Taru Meri; Tommi Kajander; Markus J Lehtinen; Hideo Iwaï; T Sakari Jokiranta; Adrian Goldman
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

Review 6.  Highly penetrant alleles in age-related macular degeneration.

Authors:  Anneke I den Hollander; Eiko K de Jong
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-06       Impact factor: 6.915

Review 7.  Complement in ANCA-associated vasculitis: mechanisms and implications for management.

Authors:  Min Chen; David R W Jayne; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2017-03-20       Impact factor: 28.314

8.  Biological effects of inhaled hydraulic fracturing sand dust. VI. Cardiovascular effects.

Authors:  Kristine Krajnak; Hong Kan; Kristen A Russ; Walter McKinney; Stacey Waugh; Wen Zheng; Michael L Kashon; Claud Johnson; Jared Cumpston; Jeffrey S Fedan
Journal:  Toxicol Appl Pharmacol       Date:  2020-09-12       Impact factor: 4.219

Review 9.  Genetics and complement in atypical HUS.

Authors:  David Kavanagh; Tim Goodship
Journal:  Pediatr Nephrol       Date:  2010-06-06       Impact factor: 3.714

Review 10.  Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease.

Authors:  Marijn M Speeckaert; Reinhart Speeckaert; Juan J Carrero; Raymond Vanholder; Joris R Delanghe
Journal:  J Clin Immunol       Date:  2013-02-27       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.